Home › AstraZeneca Enters Into An Agreement With IntelliCyt For The Development Of High Throughput Biology Applications
 

Keywords :   


AstraZeneca Enters Into An Agreement With IntelliCyt For The Development Of High Throughput Biology Applications

2016-06-01 06:19:16| drugdiscoveryonline Home Page

IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery,antibody discovery and immuno-oncology research today announced a collaboration with AstraZeneca to further the development of high throughput biology applications to provide insights into the complex biology of disease

Tags: high development agreement applications

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »